Encompass Health Corporation (EHC) has a consensus analyst rating of Buy, based on 26 analysts covering the stock. Of those, 21 recommend buying, 4 recommend holding, and 1 recommend selling.
The analyst consensus price target for EHC is $153.00, representing a +43.4% upside from the current price of $106.7. Price targets range from a low of $153.00 to a high of $153.00.